Engineered TCR1-T cells and TCR3-T cells exhibited increased levels of IFN-γ secretion and specific cytotoxicity toward autologous tumor PDO compared to normal PDO (Fig. 5C, D). The gene discussed is IFNG; the disease is neoplasm.